Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease

Transplantation

Volumn 66, Issue 12, 1998, Pages 1641-1644

  Green, Michael ^a   Cacciarelli, Thomas V ^a   Mazariegos, George V ^a   Sigurdsson, Luther ^a   Qu, Liron ^b   Rowe, David T ^b   Reyes, Jorge ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; EPSTEIN BARR VIRUS; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNE RESPONSE; INFANT; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; VIRUS GENOME; VIRUS LOAD;

CHILD; CHILD, PRESCHOOL; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; VIREMIA;

EID: 0032573748     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199812270-00012     Document Type: Article

References (15)

1. Riddler SA, Breinig MC, McKnight JLC. Increased levels of circulating Epstein-Barr virus-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood 1994; 84: 972.
2. Savoie A, Perpete C, Carpentier L, Joncas K, Alfieri C. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 1994; 83: 2715.
3. Kenagy DN, Schlesinger Y, Weck K, Ritter JH, Gaudreault-Keener MM, Storch GA. Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease. Transplantation 1995; 60: 547.
4. Rowe DT, Qu L, Reyes J, et al. Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in peripheral blood of pediatric transplant recipients with lymphoproliferative disorders. J Clin Microbiol 1997; 35: 1612.
5. Randhawa PS, Jaffe R, Demetris AJ, et al. Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med 1992; 327: 1710.
6. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988; 133: 173.
7. Fung JJ, Todo S, Jain A, Demetris AJ, McMichael JP, Starzl TE. The Pittsburgh randomized trial of tacrolimus versus cyclosporine for liver transplantation. J Am Coll Surg 1996; 183: 117.
8. Rooney CM, Loftin SK, Holladay MS, Brenner MK, Krance RA, Heslop HB. Early identification of Epstein-Barr virus-associated post-transplant lymphoproliferative disease. Br J Haematol 1995; 89: 98.
9. Green M, Reyes J, Rowe D. New strategies in the prevention and management of Epstein-Barr virus infections and posttransplant lymphoproliferative disease following solid organ transplantation. Curr Opin Solid Organ Transplant 1998; 3: 143.
10. Hanto DW, Frizzera G, Gajl-Peczalska KJ, et al. Epstein-Barr virus induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med 306; 913: 1982.
11. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Balfour HH, Simmons RL, Najarian JS. Acyclovir therapy of Epstein-Barr virus-induced posttransplant lymphoproliferative diseases. Transplant Proc 17; 89: 1985.
12. Lin JC, Smith MC, Pagano JS. Prolonged inhibitory effect of 9-(1,3-dihyroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus. J Virol 1984; 50: 50.
13. McKnight JLC, Cen H, Riddler S, et al. EBV gene expression, EBNA antibody responses and EBV+ peripheral blood lymphocytes in post-transplant lymphoproliferative disease. Leuk Lymphoma 1994; 15: 9.
14. Yao Qy, Ogan P, Rowe M, Wood M, Rickinson AB. Epstein-Barr virus-infected B cells persist in the circulation of acyclovir treated carriers. Int J Cancer 1989; 43: 67.
15. Wu TT, Swerdlow SH, Locker J, et al. Recurrent Epstein-Barr virus-associated lesion in organ transplant recipients. Hum Pathol 1996; 27: 157.